Annual Current Liabilities
$16.12 M
+$5.94 M+58.38%
31 December 2021
Summary:
Concert Pharmaceuticals annual total current liabilities is currently $16.12 million, with the most recent change of +$5.94 million (+58.38%) on 31 December 2021. During the last 3 years, it has risen by +$5.94 million (+58.38%).CNCE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$17.40 M
+$1.24 M+7.67%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly total current liabilities is currently $17.40 million, with the most recent change of +$1.24 million (+7.67%) on 30 September 2022.CNCE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | +58.4% | +44.7% |
5 y5 years | +84.3% | +26.5% |
CNCE Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -13.4% | -14.6% |
Concert Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $17.40 M(+7.7%) |
June 2022 | - | $16.16 M(+7.1%) |
Mar 2022 | - | $15.08 M(-6.4%) |
Dec 2021 | $16.12 M(+58.4%) | $16.12 M(+34.1%) |
Sept 2021 | - | $12.02 M(+38.7%) |
June 2021 | - | $8.67 M(+4.4%) |
Mar 2021 | - | $8.30 M(-18.4%) |
Dec 2020 | $10.18 M(-41.1%) | $10.18 M(+38.1%) |
Sept 2020 | - | $7.37 M(-23.4%) |
June 2020 | - | $9.62 M(-32.6%) |
Mar 2020 | - | $14.27 M(-17.4%) |
Dec 2019 | $17.27 M(+97.4%) | $17.27 M(+25.5%) |
Sept 2019 | - | $13.75 M(+85.8%) |
June 2019 | - | $7.40 M(-6.5%) |
Mar 2019 | - | $7.92 M(-9.5%) |
Dec 2018 | $8.75 M(+35.7%) | $8.75 M(+19.1%) |
Sept 2018 | - | $7.34 M(+19.1%) |
June 2018 | - | $6.17 M(-6.1%) |
Mar 2018 | - | $6.57 M(+1.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $6.45 M(+15.7%) | $6.45 M(-13.5%) |
Sept 2017 | - | $7.45 M(+22.6%) |
June 2017 | - | $6.08 M(+24.0%) |
Mar 2017 | - | $4.90 M(-12.0%) |
Dec 2016 | $5.57 M(-15.9%) | $5.57 M(-19.3%) |
Sept 2016 | - | $6.90 M(-1.6%) |
June 2016 | - | $7.01 M(+28.1%) |
Mar 2016 | - | $5.47 M(-17.4%) |
Dec 2015 | $6.63 M(-64.4%) | $6.63 M(-13.0%) |
Sept 2015 | - | $7.62 M(-28.0%) |
June 2015 | - | $10.59 M(-27.3%) |
Mar 2015 | - | $14.55 M(-21.8%) |
Dec 2014 | $18.62 M(+17.0%) | $18.62 M(-8.6%) |
Sept 2014 | - | $20.38 M(+3.7%) |
June 2014 | - | $19.65 M(+16.4%) |
Mar 2014 | - | $16.88 M(+6.1%) |
Dec 2013 | $15.92 M(+101.2%) | $15.92 M(+0.4%) |
Sept 2013 | - | $15.85 M(+100.4%) |
Dec 2012 | $7.91 M(-23.0%) | $7.91 M |
Dec 2011 | $10.27 M | - |
FAQ
- What is Concert Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CNCE is $16.12 M
What is the all time high annual current liabilities for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual total current liabilities is $18.62 M
What is Concert Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CNCE is $17.40 M
What is the all time high quarterly current liabilities for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly total current liabilities is $20.38 M